Europe’s drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences’ remdesivir can be used to treat COVID-19 patients who do not need oxygen support. The indication for extended use, if approved, would allow the antiviral treatment to be given to…
